Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Oral Omeprazole vs IV Pantoprazole in Peptic Ulcer Bleeding
NCT04394663Recruiting
- Start
- Oct 2020
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of omeprazole in peptic ulcer disease (PUD) (2 arms). Primary endpoint: Rate of 3-day peptic ulcer rebleeding. Started Oct 2020; status: recruiting.
02
Drugs
omeprazole
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04394663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394663.